PRIG
MRK icon

Payden & Rygel Investment Group’s Merck MRK Stock Holding History

Payden & Rygel Investment Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$14.9M Sell
120,150
-11,600
-9% -$1.49M 1.2% 41
2024
Q1 		$17.4M Buy
+131,750
New +$16.2M 0.82% 39
2023
Q3 		$17.2M Buy
+166,850
New +$18M 1.17% 26

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Payden & Rygel Investment Group's MRK Position: Q2 2024 in Review

Payden & Rygel Investment Group reduced its Merck (MRK) stake by 8.8% in Q2 2024, selling an estimated $1.49M and leaving 120,150 shares worth $14.9M. The position accounts for 1.2% of the portfolio, ranked #41.

Payden & Rygel Investment Group first reported a position in MRK in Q3 2023 and has held it in 3 quarters since. The position peaked at $17.4M in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Payden & Rygel Investment Group held 120,150 shares of Merck worth $14.9M as of Q2 2024.
  • Payden & Rygel Investment Group sold 11,600 Merck shares in Q2 2024, an estimated $1.49M.
  • Merck made up 1.2% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #41 holding.
  • Payden & Rygel Investment Group first reported a position in Merck in Q3 2023 and has held it in 3 quarters since.
  • Payden & Rygel Investment Group's Merck position peaked at $17.4M in Q1 2024.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.